AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2014
Oct 15, 2014
30339_dirs_2014-10-15_a5b666da-5c9f-4f75-8e4e-e1c815dea46d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2014-10-10
Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-10-10 | Common Stock | A | 29.3700 | $44.2900 | Acquired | 24395.7342 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 826423.6917 | Direct |
| Common Stock | 2693.6600 | Indirect |
More from WEST PHARMACEUTICAL SERVICES INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 12